Major Developments:
BrainAurora-B (06681): Its product for cognitive function assessment in patients with depression has received a Class II Medical Device Registration Certificate from the Beijing Municipal Medical Products Administration.
Ocumension-B (01477): Its fluocinolone acetonide intravitreal implant has been approved by the National Medical Products Administration for manufacturing in mainland China.
Crypto Flow (08198) plans to collaborate with DC ARK on artificial intelligence computing power and artificial intelligence data center businesses.
SKB Bio (06990): The marketing application for a new indication of its core product TROP2 ADC sac-TMT (sacituzumab tirumotecan) has been accepted by the National Medical Products Administration.
Livzon Pharmaceutical (01513): Its Wandaitang Granules have obtained a Drug Registration Certificate.
Hengrui Medicine (01276): Its Class 1 innovative drug remimazolam besylate for injection has been approved for a new indication.
Operating Results:
Lufax (06623) released its third-quarter results, with total revenue of RMB 6.18 billion and new consumer finance loans growing 25.2% year-on-year.
Huaneng Power International (00902) reported net profit attributable to shareholders of RMB 7.822 billion for the first three quarters, down 47.29% year-on-year.
Huaqin Technology (03296) reported net profit attributable to shareholders of RMB 4.323 billion for the first three quarters, up 39.53% year-on-year.
Guangdong Investment (00270) reported profit attributable to owners of the company of HK$4.362 billion for the first three quarters, up 7.3% year-on-year.
Fosun Pharma (02196) released its first three quarters results, with net profit attributable to shareholders of RMB 2.667 billion, up 5.71% year-on-year.
China Communications Construction (01800) reported new contract value of RMB 1,171.296 billion for the first three quarters, down 12.59% year-on-year.
Hengrui Medicine (01276) reported net profit attributable to shareholders of approximately RMB 6.923 billion for the first three quarters, up 20.38% year-on-year.
Pop Mart (09992) saw overall revenue decline 45%-50% year-on-year in the third quarter.
Ferretti (09638) reported new orders of EUR 665 million for the first three quarters, down approximately 13.8% year-on-year.
HSBC Holdings (00005) released its first three quarters results, with profit after tax of USD 22.9 billion, up 28% year-on-year.
Comments